Rouas-Freiss N - Search Results

1

In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis.

Carcelain G, Rouas-Freiss N, Zorn E, Chung-Scott V, Viel S, Faure F, Bosq J, Hercend T. Carcelain G, et al. Int J Cancer. 1997 Jul 17;72(2):241-7. doi: 10.1002/(sici)1097-0215(19970717)72:2<241::aid-ijc7>3.0.co;2-r. Int J Cancer. 1997. PMID: 9219827

2

Exosomes bearing HLA-G are released by melanoma cells.

Riteau B, Faure F, Menier C, Viel S, Carosella ED, Amigorena S, Rouas-Freiss N. Riteau B, et al. Hum Immunol. 2003 Nov;64(11):1064-72. doi: 10.1016/j.humimm.2003.08.344. Hum Immunol. 2003. PMID: 14602237

3

Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.

Rouas-Freiss N, Bruel S, Menier C, Marcou C, Moreau P, Carosella ED. Rouas-Freiss N, et al. Int J Cancer. 2005 Oct 20;117(1):114-22. doi: 10.1002/ijc.21151. Int J Cancer. 2005. PMID: 15880415

4

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.

Menier C, Riteau B, Carosella ED, Rouas-Freiss N. Menier C, et al. Int J Cancer. 2002 Jul 1;100(1):63-70. doi: 10.1002/ijc.10460. Int J Cancer. 2002. PMID: 12115588

5

HLA-G gene activation in tumor cells involves cis-acting epigenetic changes.

Mouillot G, Marcou C, Rousseau P, Rouas-Freiss N, Carosella ED, Moreau P. Mouillot G, et al. Int J Cancer. 2005 Mar 1;113(6):928-36. doi: 10.1002/ijc.20682. Int J Cancer. 2005. PMID: 15514928

6

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. Rouas-Freiss N, et al. Cancer Res. 2005 Nov 15;65(22):10139-44. doi: 10.1158/0008-5472.CAN-05-0097. Cancer Res. 2005. PMID: 16287995

7

In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.

Loumagne L, Baudhuin J, Favier B, Montespan F, Carosella ED, Rouas-Freiss N. Loumagne L, et al. Int J Cancer. 2014 Nov 1;135(9):2107-17. doi: 10.1002/ijc.28845. Epub 2014 Apr 7. Int J Cancer. 2014. PMID: 24623585

8

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes.

Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N. Le Gal FA, et al. Int Immunol. 1999 Aug;11(8):1351-6. doi: 10.1093/intimm/11.8.1351. Int Immunol. 1999. PMID: 10421792

9

HLA-G expression in human melanoma cells: protection from NK cytolysis.

Adrián Cabestré F, Moreau P, Riteau B, Ibrahim EC, Le Danff C, Dausset J, Rouas-Freiss N, Carosella ED, Paul P. Adrián Cabestré F, et al. J Reprod Immunol. 1999 Jul;43(2):183-93. doi: 10.1016/s0165-0378(99)00037-6. J Reprod Immunol. 1999. PMID: 10479054

10

Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.

Rouas-Freiss N, Moreau P, Menier C, LeMaoult J, Carosella ED. Rouas-Freiss N, et al. Semin Cancer Biol. 2007 Dec;17(6):413-21. doi: 10.1016/j.semcancer.2007.07.003. Epub 2007 Jul 17. Semin Cancer Biol. 2007. PMID: 17881247 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters